Shares of Aphria Inc (NYSE:APHA) have earned a consensus rating of “Buy” from the ten research firms that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $8.21.

Several analysts have recently issued reports on APHA shares. Cantor Fitzgerald increased their price objective on Aphria from $9.50 to $9.85 and gave the company an “overweight” rating in a research note on Friday, May 8th. Zacks Investment Research cut Aphria from a “buy” rating to a “hold” rating in a research note on Tuesday, June 16th. CIBC increased their price objective on Aphria from $6.00 to $7.00 and gave the company a “neutral” rating in a research note on Thursday, April 16th. Eight Capital upgraded Aphria to a “buy” rating in a research note on Thursday, April 16th. Finally, Stifel Nicolaus raised their price target on Aphria from $4.50 to $5.30 and gave the company a “hold” rating in a research note on Thursday, April 16th.

Institutional investors have recently bought and sold shares of the business. Morgan Stanley increased its position in shares of Aphria by 126.0% during the first quarter. Morgan Stanley now owns 2,057,184 shares of the company’s stock worth $6,295,000 after purchasing an additional 1,146,772 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Aphria by 345.7% during the fourth quarter. Renaissance Technologies LLC now owns 1,434,700 shares of the company’s stock worth $7,495,000 after purchasing an additional 1,112,800 shares in the last quarter. Public Sector Pension Investment Board increased its position in shares of Aphria by 20.2% during the first quarter. Public Sector Pension Investment Board now owns 800,405 shares of the company’s stock worth $2,412,000 after purchasing an additional 134,705 shares in the last quarter. Swiss National Bank increased its position in shares of Aphria by 1.5% during the first quarter. Swiss National Bank now owns 465,100 shares of the company’s stock worth $1,393,000 after purchasing an additional 7,000 shares in the last quarter. Finally, CIBC World Markets Inc. increased its position in shares of Aphria by 2.4% during the first quarter. CIBC World Markets Inc. now owns 266,089 shares of the company’s stock worth $814,000 after purchasing an additional 6,284 shares in the last quarter. Institutional investors own 9.57% of the company’s stock.

Shares of NYSE APHA remained flat at $$4.29 during mid-day trading on Thursday. The stock had a trading volume of 3,901,002 shares, compared to its average volume of 6,505,889. The stock has a market cap of $1.24 billion, a P/E ratio of 47.67 and a beta of 2.19. The company has a quick ratio of 3.73, a current ratio of 5.19 and a debt-to-equity ratio of 0.25. Aphria has a twelve month low of $1.95 and a twelve month high of $7.60. The business’s fifty day moving average price is $4.12 and its 200-day moving average price is $4.05.

Aphria (NYSE:APHA) last announced its quarterly earnings data on Tuesday, April 14th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.06. The business had revenue of $144.40 million for the quarter, compared to analysts’ expectations of $130.74 million. Aphria had a negative return on equity of 0.30% and a net margin of 5.75%. The company’s revenue for the quarter was up 96.2% compared to the same quarter last year. During the same period last year, the firm earned ($0.20) earnings per share. As a group, analysts expect that Aphria will post -0.03 earnings per share for the current fiscal year.

About Aphria

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

Featured Article: Percentage Decliners

Analyst Recommendations for Aphria (NYSE:APHA)

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.